Ozempic Shows Some Promise for Alcohol Use Disorder
The results suggest the potential of semaglutide – the main ingredient in Ozempic and Novo’s higher-dose weight-loss drug Wegovy – and similar drugs “to fill an unmet need for the treatment of alcohol use disorder,” study leader Klara Klein of the University of North Carolina School of Medicine said in a statement.
Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...
As the medical community gains more insight into Ozempic’s full range of effects, this new development could influence both prescribing practices and patient education. If further studies ...
Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...
He also published one of the first case series that found semaglutide, the active ingredient in Ozempic, to effectively reduce alcohol consumption among six people with addiction. (The drug ...
Ozempic (semaglutide) is a brand-name drug prescribed to treat certain conditions, such as type 2 diabetes. Ozempic has interactions with some other drugs, such as insulin, and certain supplements ...
Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback